Impaired antioxidant status in porphyria cutanea tarda

Acta Medica Bulgarica

Volumn 28, Issue , 2001, Pages 135-143

  Adjarov, D ^a   Ribarova, F ^a   Koytcheva, N ^a   Shishkov, S ^a   Ivanova, A ^a   Antonov, K ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Antioxidants; Liver diseases; Porphyria, cutanea tarda

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CHLOROQUINE; FERRITIN; GLUTATHIONE; HEPATITIS C ANTIBODY; PORPHYRIN; UROPORPHYRIN;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HEMOSIDEROSIS; HEPATITIS C; HUMAN; LIVER FUNCTION TEST; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OXIDATION; PORPHYRIA CUTANEA TARDA; PORPHYRIN METABOLISM; VITAMIN BLOOD LEVEL;

EID: 0035739932     PISSN: 03241750     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Effective control of patients with porphyria cutanea tarda by measuring plasma uroporphyrin
2. A simplified method for determination of uroporphyrinogen decarboxylase activity in human blood
3. Free radical mechanisms of ethanol toxicity
4. Hepatic glutathione deficiency in chronic hepatitis C: Quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease
5. N-Acetyl cysteine enhances the response to interferone-α in chronic hepatitis C
6. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment
7. Antioxidant status and glutathione metabolism in patients with chronic hepatitis C
8. Identification and quantification of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfides
9. Decreased production of glutathione in patients with cirrhosis
10. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake
11. Drug-induced abnormalities of liver heme biosynthesis
12. Importance and regulation of hepatic glutathione
13. Porphyria cutanea tarda
14. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
15. Vitamin E
16. Oxidation of uroporphyrinogens by hydroxyl radicals: Evidence for nonporphyrin products as potential inhibitors of uroporphyrinogen decarboxylase
17. Prospects for the prevention of free radical disease, regarding cancer and cardiovascular disease
18. The vitamin status and its adequacy in the elderly: An international overview
19. Iron overload in patients with chronic hepatitis C: A clinicopathologic study
20. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease
21. Excess iron induces hepatic oxidative stress and transforming growth factor beta 1 in genetic hemochromatosis
22. Decreased hepatic glutathione in chronic alcoholic patients
23. Hepatic fibrosis in rats fed a liquid diet with carbonyl iron
24. Iron-rich foci in chronic viral hepatitis
25. Differential depletion of carotenoids and tocopherol in liver disease
26. Vitamin E status in patients with liver cirrhosis: Normal or deficient?
27. The enzymatic one-electron reduction of porphyrins to their anion free radicals
28. The one-electron reduction of uroporphyrin I by rat hepatic microsomes
29. The effects of interferon-alpha on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis C
30. Vitamin E is protective against iron toxicity and iron induced hepatic vitamin E depletion in mice
31. In situ detection of lipid peroxidation in chronic hepatitis C: Correlation with pathological features
32. Vitamin E decreases hepatic levels of aldehyde-derived peroxidation products in rats with iron overload
33. Iron, oxidative stress and fibrogenesis
34. Free erythrocyte porphyrins in the detection of undue absorption of Pb and Fe deficiency
35. A plasma porphyrin fluorescence marker for variegate porphyria
36. Quantitative determination of porphobilinogen and porphyrins in urine and porphyrins in faeces and erythrocytes
37. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda
38. Glutathione depletion in chronic hepatitis C
39. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring of porphyria cutanea tarda - Suggestions for a handling programme
40. A rapid and accurate spectro-fluorometric method for quantification and screening of urinary porphyrins